Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.55 |
| ▸ | MAOB | P27338 | 2/20 | 0.55 |
| ▸ | CALML3 | P27482 | 6/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4206970 | 1.00 | MAOA (0.55) | MAOAMAOBCALML3CYP3A4CYP2C19 | |
| SCHEMBL4210796 | 0.83 | GRM2 (0.40) | MAOAMAOBGRM2 | |
| SCHEMBL4210800 | 0.83 | GRM2 (0.40) | MAOAMAOBGRM2 | |
| SCHEMBL5337945 | 0.82 | MAOA (0.56) | MAOAMAOBCALML3CYP3A4CYP2C19 | |
| SCHEMBL5337955 | 0.82 | MAOA (0.56) | MAOAMAOBCALML3CYP3A4CYP2C19 | |
| SCHEMBL4201973 | 0.81 | MAOA (0.56) | MAOAMAOBCYP3A4 | |
| SCHEMBL4201967 | 0.81 | MAOA (0.56) | MAOAMAOBCYP3A4 | |
| SCHEMBL16686214 | 0.78 | MAOA (0.56) | MAOAMAOBCALML3CYP3A4CYP2C19 | |
| Lithium Ion SCHEMBL5337918 | 0.77 | MAOA (0.50) | MAOAMAOBCALML3CYP3A4CYP2C19 | |
| SCHEMBL9205426 | 0.76 | MAOA (0.64) | MAOAMAOBCALML3GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090149520-A1 | OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS | PFIZER INC | 2009-06-11 | — | — | US | disclosed |
| EP-2004640-A1 | OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS | Pfizer Products Inc. (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007091147-A1 | OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS | PFIZER PRODUCTS INC. (US) | 2007-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090149520-A1 | OXAZOLIDINONES CONTAINING OXINDOLES AS ANTIBACTERIAL AGENTS | OXA1L, MT-ND4L, IL4I1 | MAOA 534/4885MAOB 709/4885CALML3 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.